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Abstract: BD
TM Calcium Assay Kits are designed for cell-based calcium mobilization high-throughput screening assays. 
The kits use a proprietary formulation including a non-fluorescent calcium indicator that becomes activated inside the cell 
and shows increased fluorescence upon calcium binding. The formulation includes a signal-enhancing reagent to maxi-
mize the signal over background in a homogeneous, no-wash assay format, based on a technology developed at BD. We 
have compared the next generation BD calcium assay kit product family to previous versions of the formulation, and to 
other commercially available homogeneous calcium assay kits. The improvements have enabled better performance on the 
cell lines and receptors that we have tested in all plate formats including 1536. 
INTRODUCTION  
  GPCRs are known to play a crucial role in the develop-
ment and progression of major diseases such as cardiovascu-
lar, respiratory, gastrointestinal, neurological, psychiatric, 
metabolic and endocrinological disorders [1]. Fluorescent 
calcium indicators, such as Fluo-3 and Fluo-4, have been 
widely used in the high-throughput screening field for 
GPCRs and other targets that result in calcium mobilization 
[2]. The protocols using Fluo-3 and Fluo-4 typically require 
time consuming washing steps before and after cells are 
loaded with fluorescent dyes. As the result of washing, cells 
are often lost from the microplates, resulting in well to well 
variation and decreased data quality. Harsh treatment of cells 
by washing can also diminish the cellular response to 
ligands.  
  Commercially available no-wash calcium assay formula-
tions were developed by several companies to increase 
screening throughput and improve data quality of calcium 
mobilization assays [3]. An evaluation of no-wash calcium 
assay formulations using human native rhabdomyosarcoma 
cells expressing endogenous urotensin-II receptor was con-
ducted by Xin et al. at Johnson & Johnson, and demonstrated 
that the BD™ Calcium Assay Kit delivered the best data 
quality by providing higher signal to background and elimi-
nating an addition artifact resulting from compound addition 
when other formulations were used [4].  
  After cells are loaded with calcium indicators, organic-
anion transporters located in the cell membrane can actively 
extrude the dyes back into extra-cellular solution. These 
transporters can be particularly active in certain cell types 
such as CHO and HeLa. In these cases, probenecid, a stan-
dard inhibitor of nonspecific anion transport, is often in-
cluded in the dye-loading solution to reduce leakage [5]. The 
necessity to prepare a probenecid stock solution adds yet one 
more step in the screening campaign. Although in general 
probenecid does not alter free calcium concentrations in the  
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cytosol, it does have an apparent toxic effect on some cells 
after prolonged incubation. In addition, probenecid was also 
shown to change the calcium flux kinetics of a cyclic nucleo-
tide gated ion channel and decrease the channel’s response to 
agonists of Gs-couple receptors in the BD
TM ACTOne GPCR 
assay [6]. To mitigate these negative effects of probenecid, 
novel calcium dye formulations were developed (BD™ PBX 
Calcium Assay Kit). Probenecid titration experiments 
showed that the PBX kit was able to detect intracellular cal-
cium flux in CHO cells in the absence of probenecid. 
  In this report we describe a second generation BD cal-
cium assay kit. Comparison of the first and second genera-
tion formulations on various cell lines and receptors in 96, 
384 and 1536-well format, showed the new formulation pro-
vides a higher signal to background and an increased robust-
ness in GPCR screening campaigns.  
MATERIALS AND METHODS  
Cell Culture 
  Cell lines were purchased from ATCC (Manassas, VA). 
CHO-K1 cells were maintained in F-12 nutrient mixture with 
10% FBS and penicillin/streptomycin (Invitrogen, Carlsbad, 
CA). CHO-K1 cells stably transfected with rat M1 mus-
carinic acetylcholine receptor (CHO-M1) were maintained in 
F-12 nutrient mixture with 10% FBS and 100 μg/ml G418 
(Invitrogen, Carlsbad, CA). CHO cells stably expressing rat 
muscarinic receptor 1 (CHO-M1) were maintained in F-12 
nutrient mixture with 10% FBS and 250 μg/ml G418. HEK 
293 cells were grown in Dulbecco’s Minimal Essential Me-
dia (DMEM) with 10% FBS and penicillin/streptomycin 
(Invitrogen, Carlsbad, CA).  
Regent Preparation for Calcium Flux Assays 
  Preparation of dye-loading solutions of BD
TM calcium 
assay kits (BD Biosciences, Rockville, MD. Table 1) were 
performed as described in the manual and illustrated in a 
flow chart (Fig. 1). Calcium 3 kit was purchased from Mo-
lecular Devices (Sunnyvale, CA), and prepared in HBSS 
buffer (Invitrogen, Carlsbad) containing 20 mM HEPES (pH 
7.4) according to the product insert sheet. Probenecid Improvements in Live Cell Analysis of G Protein Coupled Receptors  Current Chemical Genomics, 2008, Volume 2    11 
(Sigma, St Louis, MO) was included in dye-loading solu-
tions in some experiments as indicated. Agonists ATP and 
carbachol (Sigma, St Louis, MO) were prepared in 
HBSS/HEPES solution at 5X final concentrations for ex-
periments on FlexStation and FLIPR 3 (Molecular Devices, 
Sunnyvale, CA), and at 6X of the final concentrations for 
experiments on FDSS 7000 (Hamamatsu, Japan). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Flow chart of dye-loading solution preparation. 
 
Calcium Flux Assays 
Experiments in 96-well plates. CHO cells and HEK293 cells 
were plated in 100 μl culture medium on 96-well Biocoat 
poly-D lysine coated plates (BD Biosciences, Bedford, MA) 
at 50,000 cells per well. The next day, 100 μl/well dye-
loading solution was added to each well. After 1 hour of in-
cubation at 37 °C, calcium flux assays were performed with 
on-line compound addition in a FlexStation (Molecular De-
vices), with simultaneous data collection. Dose response 
curves were generated by SoftMax®Pro (Molecular De-
vices). 
  Experiments in 384-well plates. CHO-K1, CHO-M1 cells 
and HEK293 cells were plated overnight in 25 μl culture 
medium on 384-well Biocoat poly-D lysine coated plates 
(BD Biosciences, Bedford, MA) at 10,000 cells per well. 
The next day, cells were loaded with 25 μl/well dye-loading 
solution at 37 °C for 1 hour. Calcium flux assays were per-
formed with on-line compound addition by either a FlexSta-
tion or a FLIPR 3 (Molecular Devices), with concurrent data 
collection. Dose response curves were generated by Soft-
Max®Pro (Molecular Devices). For antagonist assay, CHO-
M1 cells in a 384-well plate were incubated with pirenzepine 
(Sigma, St Louis, MO) solution for 5 minutes before the 
ligand (40 nM carbachol) was added by a FlexStation.  
  Experiments in 1536-well plates. The experimental pro-
tocol was modified based on Liu et al. at NIH [7]. CHO-M1 
cells were seeded overnight in 3 μl culture medium on 1536-
well black wall clear bottom plates (Greiner) at 2000 cells 
per well. The next day, cells were loaded with 2.5 μl/well 
dye-loading solution at 37 °C for 1 hour. A FDSS 7000 
(Hamamatsu, Japan) was used for calcium mobilization ex-
periments, and 1 μl agonist or buffer was added to each well 
by the instrument and data were recorded simultaneously. 
Dose response curves were generated by Prism (Graphpad, 
San Diego, CA). 
RESULT 
Comparison of First and Second Generation of BD
TM 
Calcium Assay Kits 
  To assess the performance of the BD calcium assay kits, 
the endogenous P2Y receptors in HEK293 [8] and CHO-K1 
[9] cells were compared side by side using identical assay 
conditions. To maintain a true no-wash assay, culture me-
dium was not removed before dye-loading. HEK 293 cells in 
general do not require probenecid for dye-loading, and there-
fore probenecid was not included in the dye-loading solution 
(Fig. 2A). However, probenecid was added to prevent dye 
leakage when CHO cells were assayed (Fig. 2B). The fluo-
rescent signal change at different concentrations of the 
ligand ATP was calculated and plotted. As shown in Fig. (2), 
the second generation kit (BD
TM High Performance Calcium 
Assay Kit) exhibited improved signal to background in both 
HEK293 and CHO cells at the highest ATP concentrations, 
while the EC50 values remained similar. 
  Antagonsit assay was also conducted using both genera-
tions of calcium assay kits. Pirenzepine, a known muscarinic 
receptor inhibitor, was incubated with CHO cells overex-
pressing rat muscarinic receptor M1 for 5 minutes before the 
cells were applied with carbachol at EC80 value (40 nM in 
this case). As shown in Fig. (3), the assay using the second 
generation calcium assay kit delivered higher signal to back-
ground than the assay using the first generation kit. The IC 
50 value remained similar between the two assays. 
  Assay miniaturization increases the speed and efficiency 
of screening and lead discovery. However, miniaturization of 
cell-based assays to a 1536-well format is challenging, due 
in part to difficulties in cell washing and obtaining appropri-
ate plating densities. The impact of cell washing can be re-
duced by employing homogeneous true no-wash assay for-
mats. We therefore evaluated the performance of both BD 
calcium formulations on CHO cells stably expressing the rat 
muscarinic receptor M1 (CHO-M1) in a 1536-well format 
using an FDSS 7000. Similar to the results obtained in 96 
and 384-well formats above, the BD
TM High Performance 
Table 1.  Summary of BD Calcium Assay Kits 
  Regular Applications  Probenecid Sensitive Applications 
First generation  BD
TM Calcium Assay Kit  BD
TM PBX Calcium Assay Kit 
Second generation  BD
TM High Performance
 Calcium Assay Kit  BD
TM PBX High Performance Calcium Assay Kit 
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Calcium Assay Kit provided higher response to carbachol, 
an agonist of muscarinic receptor, than the first generation 
kit (Fig. 4A). Both kits delivered robust signals, and there 
was no significant difference in EC50 and Z’ values [10] 
(Fig. 4B). 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Response of muscarinic receptor to its antagonist, 
pirenzepine.  
Dose response curves of pirenzepine in CHO-M1 cells in the pres-
ence of 40 nM carbachol at 384-well format. Signal to background 
are 4.8 and 5.4, IC50 values are 224 nM and 200 nM using the first 
and second generation kits, respectively. 
 BD
TM High Performance Calcium Assay Kit (second genera-
tion).  
 BD
TM Calcium Assay Kit (first generation). 
 
Probenicid-Free Screening of CHO Cells with the BD
TM 
PBX Calcium Assay Kit  
  Because of high organic anion transporter activity in 
CHO cells, fluorescent calcium dyes are poorly retained in 
the absence probenecid. In a standard protocol for CHO cell 
calcium flux assays using Fluo-3, Fluo-4 and other commer-
cial kits, 2.5 mM probenecid is required to achieve the opti-
mal signal. Moreover, when CHO cells are transfected with 
GPCR genes, overexpression of the GPCR can have a nega-
tive impact on the host cells’ ability to tolerate prolonged 
incubation with probenecid. The BD
TM PBX Calcium Assay 
Kit was specially designed for assays that are sensitive to 
probenecid, and the special formulation of the PBX kit helps 
increase dye retention in cells. To assess the performance, a 
probenecid titration assay (0 to 2 mM probenecid) was per-
formed and measured on a FlexStation using the first genera-
tion BD calcium assay kit, BD PBX calcium assay kit and a 
Calcium 3 kit purchased from Molecular Devices. The data 
indicates that probenecid is not required for dye-loading 
CHO cells if the BD
TM PBX Calcium Assay Kit is used (Fig. 
5A) while 0.5 mM probenecid is sufficient for the BD
TM 
Calcium Assay Kit (Fig. 5B). In contrast, the Calcium 3 kit 
requires at least 2 mM probenecid to exhibit a response (Fig. 
5D). 
  The performance of first generation BD kits and the Cal-
cium 3 kit in the absence of probenecid was also compared 
side by side using a FLIPR 3. Endogenous P2Y receptor in 
CHO cells (Fig. 6) was used as an example. In CHO cells, 
the BD
TM PBX Calcium Assay Kit was observed to generate 
18,000 RFU of response to ATP and BD
TM Calcium Assay 
Kit had 3000 RFU of response, while the Calcium 3 kit 
failed to deliver a positive signal. High fluorescent back-
ground in wells loaded with Calcium 3 kit indicated that the 
fluorescent calcium dyes were pumped out of cells in the 
absence of probenecid. When the agonist was added to the 
wells after dye-loading, the fluorescent molecules in ex-
tracellular environment were diluted and therefore a signifi-
cant drop of fluorescent signal was observed. Because of 
poor dye-retention in cells, no fluorescent calcium flux sig-
nal could be detected by Calcium 3 kit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Response of endogenous P2Y receptor to ATP.  
A. Dose response curves of ATP in HEK 293 cells in the absence of probenecid in 384-well format. Signal to background are 3.9 and 4.6, 
EC50 values are 1.1 μM and 1.5 μM using the first and second generation kits, respectively. 
B. Dose response curve of ATP in CHO-K1 cells in the presence of 2.5 mM probenecid in 96-well format. Signal to background are 5.0 and 
5.5, EC50 values are 67 nM and 58 nM using the first and second generation kits, respectively. 
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Fig. (4). Response of muscarinic receptor to carbachol in the presence of 2.5 mM probenecid in 1536-well format.  
A. CHO-M1 cells treated with 1 μM carbachol. 
B. Carbachol dose response curves plotted by Prism (GraphPad). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Probenecid titrations on CHO-M1 cells using different kits in 384-well format. 
A. ATP dose response curves in the absence of probenecid.  
B. ATP dose response curves in the presence of 0.5 mM probenecid.  
C. ATP dose response curves in the presence of 1 mM probenecid.  
D. ATP dose response curves in the presence of 2 mM probenecid. 
  Recently, further improvements were developed that en-
hance the performance of the PBX calcium assay kit, (BD
TM 
PBX High Performance Calcium Assay Kit). Compared with 
the first generation kit, the new formulation provides higher 
signal to background while maintaining EC50 values (Fig. 
7). Both kits can be miniaturized to 1536-well format with 
high Z’ values (Fig. 8). 
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Fig. (6). Comparison of homogeneous calcium assays on FLIPR 
3 (384-well). 
Kinetic data of CHO-K1 cells treated with 3 μM ATP.  
 BD
TM PBX Calcium Assay Kit.  
 BD
TM Calcium Assay Kit.  
 Calcium 3 Kit. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Comparison of first and second generation BD
TM PBX 
calcium assay kit in 384-well format 
ATP dose response curves of CHO-K1 cells in the absence of pro-
benecid. Signal to background are 3.2 and 2.5, EC50 values are 
62.6 nM and 72.6 nM using the first and second generation kits, 
respectively. 
 
DISCUSSION 
  The BD calcium assay kit product family was tested 
against previous kit formulations and to other commercially 
available homogeneous calcium assay kits, and was found to 
provide better performance on the cell lines and receptors 
tested. The formulation of BD
TM Calcium Assay Kits in-
cludes a unique signal-enhancing reagent to maximize the 
signal over background. Components such as enhancers, 
quenchers and other molecules can cause interference with 
test compounds, particularly small peptides, resulting in po-
tential false negatives. During development of the current 
formulations, we tested a diversity of cell lines (e.g. CHO-
K1, HEK293, U2OS, HeLa) and receptors (e.g. A2b recep-
tor, -adrenoceptor, DRD5 receptor, CRF2 receptor, Gluca-
gon receptor, PACAP receptor, secretin receptor, EP4 recep-
tor, GIP receptor, muscarinic receptor, P2Y receptor, hista-
mine H1 receptor, CCR2 receptor and MCH receptor 2) in 
an attempt to exclude interfering components. Following 
commercialization, others have extensively validated these 
formulations on their own well-characterized assays (per-
sonal communication). To our knowledge, no adverse phar-
macological effects of the formulations’ components on re-
ceptors or cells have been reported. However, because bio-
logical events are complicated and each cell line and receptor 
behaves differently, it is often valuable to evaluate several 
calcium assay formulations to identify the best performer for 
the specific assay and target. 
  In conclusion, we have developed a second generation 
BD calcium assay kits that provide higher signal to back-
ground and better performance than the previous generation 
kits. The new kits utilize novel fluorescent calcium indica-
tors with improved dye-loading and retention efficiency. The 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (8). Comparison of first and second generation BD
TM PBX 
calcium assay kit in 1536-well format 
A. CHO-M1 cells treated with and without 1 μM carbacol using 
BD
TM High Performance PBX Calcium Assay Kit in absence of 
probenecid. Signal to background is 3.1, and Z’ value is 0.84 (n = 
12). 
B. CHO-M1 cells treated with and without 1 μM carbachol using 
BD
TM PBX Calcium Assay Kit in absence of probenecid. Signal to 
background is 2.1, and Z’ value is 0.79. 
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improvements have enabled better data quality on calcium 
mobilization assays in high throughput-screening environ-
ment. 
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